<h2 id="mechanism-of-action">Mechanism of Action</h2>
<p>Inhibit COX enzyme which prevents prostaglandins from being formed (which are inflammatory mediators) <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></p>
<h3 id="cox-1">COX 1</h3>
<p>maintain normal renal function, GI tract mucosal protection, thromboxane</p>
<h3 id="cox-2">COX 2</h3>
<p>Mediates pain, fever, inflammation</p>
<h2 id="examples">Examples</h2>
<p>[[Ibuprofen]]
  [[Ketorolac]]</p>
<h2 id="nsaid-complications">NSAID Complications</h2>
<p>Generally, the complications are a result of inhibiting COX-1</p>
<ul>
  <li>Dyspepsia, GIT ulceration</li>
  <li>Platelet dysfunction</li>
  <li>Renal impairment by inhibiting PG induced vasodilation of afferent glomerular arterioles</li>
</ul>
<p>Inhibition of COX-2 has been linked to several adverse cardiac outcomes.</p>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <table>
        <tbody>
          <tr>
            <td>[[@shaferStoeltingPharmacologyPhysiology2015</td>
            <td>Steven L. Shafer, James P. Rathmell, Pamela Flood, Stoelting's pharmacology and physiology in anesthetic practice, 2015]]</td>
          </tr>
        </tbody>
      </table>
      <p><a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>